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The catalytic domain of the guanine nucleotide exchange factor (GEF) Son of Sevenless (SOS) binds to Ras and promotes the release of guanosine diphosphate (GDP) so that Ras can bind to guanosine triphosphate (GTP) and adopt an active conformation (1) . Early studies revealed that the Src homology 2 (SH2) and SH3 domain-containing adaptor protein growth factor receptor-bound protein 2 (Grb2) binds to a C-terminal proline-rich region of SOS and recruits SOS to activated growth factor receptors (2) . The recruitment of SOS to the plasma membrane is necessary for the activation of Ras (3) (4) (5) . However, as additional N-terminal regions of SOS ( Fig. 1 ) became implicated in the increasingly complex regulation of SOS, the role of Grb2 has appeared less essential than previously thought.
Elegant structural and biochemical studies from the laboratories of Dafna Bar-Sagi and John Kuriyan have helped unveil much of the complexity of the interplay between SOS and Ras. X-ray crystallographic analysis of SOS fragments initially revealed that, in addition to the presence of nucleotide-free Ras at the catalytic site, a second SOS-bound Ras molecule is loaded with GTP and associated with the Ras exchange motif (REM) of SOS (6) . The REM binds to a key helical hairpin loop structure in the core catalytic, CDC25-homology, domain that is responsible for displacing the effector loop of Ras and releasing GDP (Fig. 1B) . By comparison with a crystal structure lacking bound Ras, Freedman et al. (7) established that allosteric regulation of SOS by the second Ras molecule occurs through a rotation of the SOS REM domain and, in turn, that of the hairpin at the catalytic site. This motion relieved steric occlusion of the catalytic site and allowed the binding of Ras and nucleotide release. Consequently, the introduction of a Ras Tyr 64 →Ala 64 mutant that could bind to the allosteric site of SOS but not the active site increased the nucleotide release rate 75-fold over that catalyzed by unstimulated SOS (7) . A comparison with other available structures indicated that the helical hairpin loop of RasGRF1 (Ras protein-specific guanine nucleotide-releasing factor 1) is buttressed by projections extending from the CDC25 domain to prevent it from occupying an inhibitory conformation, whereas the helical hairpin loop of Epac2, a GEF for the small guanosine triphosphatase (GTPase) Rap, might be regulated similarly to that of SOS (7) . A number of Rap GEFs, including Epac2, have Ras association (RA) domains, similar to those found in Ras effectors, located immediately N-terminal to their CDC25 domains (1) . Although the binding of Ras is known to influence the subcellular localization of these Rap GEFs (8, 9) , Ras proteins have not been reported to allosterically activate them.
So where does the Ras-GTP that activates SOS come from and why does it matter to the cell? To address the latter issue, Boykevisch et al. (10) generated a GTP-bound mutant, Ras Ala 59 →Gly 59 , Asp 38 →Glu 38 , that binds to the allosteric site of SOS but not to the Ras-binding domain of the Ras effector Raf-1. This mutant increased the amplitude as well as the duration of epidermal growth factor (EGF)-induced activation of extracellular signal-regulated kinase (ERK) in a SOS-dependent manner. The Ras "enhancer" mutant did not promote ERK activation in the absence of EGF stimulation, presumably because of the previously documented ability of the SOS Dbl homology (DH) domain to bind to the REM or allosteric Ras-binding site and preclude the activation of SOS (11) .
Despite the recruitment of SOS to the plasma membrane upon T cell receptor (TCR) activation, the diacylglycerol (DAG)-activated Ras GEF Ras guanine nucleotide-releasing protein 1 (RasGRP1) is also activated by the TCR. RasGRP1-deficient thymocytes are developmentally arrested despite recruitment of SOS to the TCR complex, suggesting that T cell activation of Ras in these mice cannot be compensated for by SOS (12) . Membrane targeting of SOS also failed to enhance activation of Ras-ERK signaling in the absence of RasGRP1 in T or B cells (13) . Thus, SOS in T cells cannot operate efficiently in the absence of active RasGRP1. So what use is SOS to a lymphocyte? Turning to previously established B cell lines that lack either all RasGRP or all SOS isoforms and submaximally stimulating their B cell receptors (BCRs), Roose et al. found that the loss of either class of Ras GEF resulted in a similar reduction and delay in ERK activation (13) . This suggested that with physiologically relevant BCR stimulation, both GEFs contribute to the cellular response in a concerted fashion. Mutation of SOS helped narrow down its dependence on RasGRP1 to the allosteric Ras-binding REM. So, could RasGRP1 be priming SOS with Ras-GTP to bind its REM and boost SOS-dependent Ras activation at low concentrations of ligand? This indeed seems to be the case; mutation of the REM resisted the advances of RasGRP1 whereas a Ras enhancer mutant, similar to that used by Boykevisch et al., mimicked the action of RasGRP1 (13) . Although SOS activation is achieved with slower kinetics in cells lacking leukocyte RasGRPs than in wild-type cells, this partnership maintains a low abundance of basal Ras-GTP and robust activation of Ras in response to a modest extracellular stimulus (13) . This also suggests that SOS will be more readily activated in cells that contain a higher basal abundance of Ras-GTP.
The pleckstrin homology (PH) domain of SOS has long been known to play a role in the recruitment of SOS to the plasma membrane. However, the lipid responsible for this translocation was unclear (14) . Zhao et al. have now found that, like SOS, phospholipase D 2 (PLD 2 ) is recruited to growth factor receptors by Grb2 (15) . Once at the membrane, it produces phosphatidic acid (PA) that binds to the PH domain of SOS to further promote membrane binding and Ras activation (15, 16) . The integrin lymphocyte function-associated antigen-1 (LFA-1) also activates PLD 2 in T cells in which PA is dephosphorylated to produce DAG and promote RasGRP1 activation (17) . Although Grb2 and PA could differentially regulate SOS, possibly targeting SOS to different intracellular compartments, it is likely that they cooperate to activate Ras. Additionally, the ability of PA to bind to Raf may permit differential signaling through the Raf-MEK (mitogen-activated or extracellular signal-regulated protein kinase kinase)-ERK pathway rather than through other Ras effector pathways (18) (Fig. 1C) .
A final twist in the regulation of SOS is the presence of two histone-like folds in its N terminus. It is unprecedented for such nucleotide-binding domains to exist outside of the nucleus, making it difficult to predict their function. Computational modeling techniques predicted the formation of ion pair interactions between aspartic acid residues within the histone-like domain and Arg 552 in the helical linker that connects the DH and PH domains of SOS to the REM (19) . Consistent with this, mutation of Asp 140 or Arg 552 completely abolished the interaction between the isolated histone-like domain and a DH-PH-REM-CDC25 protein fragment in vitro. Intriguingly, mutations in SOS contribute to Noonan syndrome (20) (21) (22) , one of several neuro-cardio-facial-cutaneous disorders that arise from autosomal dominant inheritance of mutations within various Ras-ERK pathway encoding genes (23) . Whereas mutations throughout SOS have been found in Noonan syndrome patients, Arg 552 is the most frequently altered residue (Fig. 1A) (20) (21) (22) . This suggests that association of the histone-like domain with the PH-REM linker may keep SOS in an inactive conformation before cellular stimulation, an event that can be overridden in patients with Noonan syndrome.
PA and allosteric Ras may play multiple roles in SOS activation. In addition to recruiting SOS to the plasma membrane, the binding of PA to the PH domain of SOS may also relieve SOS of the steric hindrance from the DH and PH domains that appears to otherwise prevent the binding of allosteric Ras to SOS (11) . Because of its farnesylated C terminus, allosteric Ras in turn may contribute to the membrane localization of SOS. Whether or how intramolecular binding of the histonelike domain to the PH-REM linker is regulated and what impact it might have on SOS activity remain to be determined. However, a positively charged surface on the histone-like domain is well positioned to provide a fourth membrane anchorage point or interaction site for other proteins (19) . Much has been learned about SOS since its discovery in 1992 (24), but it is clear that its regulation has more stories to tell. With so many means of regulation, perhaps pharmacological inhibitors might now be developed to further investigate SOS function or even target its inhibition in disease. PA can also be converted to DAG by PA phosphatase. DAG produced in this way or through the action of phospholipase C-γ contributes to RasGRP1 activation, either directly or through protein kinase C. Ras-GTP generated by RasGRP1 can bind to the REM of SOS, thus lowering the threshold for further activation of Ras.
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